These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33851153)

  • 1. Functional evaluation of the P681H mutation on the proteolytic activation the SARS-CoV-2 variant B.1.1.7 (Alpha) spike.
    Lubinski B; Fernandes MHV; Frazier L; Tang T; Daniel S; Diel DG; Jaimes JA; Whittaker GR
    bioRxiv; 2021 Nov; ():. PubMed ID: 33851153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional evaluation of the P681H mutation on the proteolytic activation of the SARS-CoV-2 variant B.1.1.7 (Alpha) spike.
    Lubinski B; Fernandes MHV; Frazier L; Tang T; Daniel S; Diel DG; Jaimes JA; Whittaker GR
    iScience; 2022 Jan; 25(1):103589. PubMed ID: 34909610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants.
    Gellenoncourt S; Saunders N; Robinot R; Auguste L; Rajah MM; Kervevan J; Jeger-Madiot R; Staropoli I; Planchais C; Mouquet H; Buchrieser J; Schwartz O; Chakrabarti LA
    J Virol; 2022 Oct; 96(19):e0130122. PubMed ID: 36121299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The P681H Mutation in the Spike Glycoprotein of the Alpha Variant of SARS-CoV-2 Escapes IFITM Restriction and Is Necessary for Type I Interferon Resistance.
    Lista MJ; Winstone H; Wilson HD; Dyer A; Pickering S; Galao RP; De Lorenzo G; Cowton VM; Furnon W; Suarez N; Orton R; Palmarini M; Patel AH; Snell L; Nebbia G; Swanson C; Neil SJD
    J Virol; 2022 Dec; 96(23):e0125022. PubMed ID: 36350154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spike Protein Cleavage-Activation in the Context of the SARS-CoV-2 P681R Mutation: an Analysis from Its First Appearance in Lineage A.23.1 Identified in Uganda.
    Lubinski B; Frazier LE; Phan MVT; Bugembe DL; Cunningham JL; Tang T; Daniel S; Cotten M; Jaimes JA; Whittaker GR
    Microbiol Spectr; 2022 Aug; 10(4):e0151422. PubMed ID: 35766497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant.
    Liu Y; Liu J; Johnson BA; Xia H; Ku Z; Schindewolf C; Widen SG; An Z; Weaver SC; Menachery VD; Xie X; Shi PY
    Cell Rep; 2022 May; 39(7):110829. PubMed ID: 35550680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteolytic Activation of SARS-CoV-2 Spike at the S1/S2 Boundary: Potential Role of Proteases beyond Furin.
    Tang T; Jaimes JA; Bidon MK; Straus MR; Daniel S; Whittaker GR
    ACS Infect Dis; 2021 Feb; 7(2):264-272. PubMed ID: 33432808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrinsic furin-mediated cleavability of the spike S1/S2 site from SARS-CoV-2 variant B.1.1.529 (Omicron).
    Lubinski B; Jaimes JA; Whittaker GR
    bioRxiv; 2022 Jul; ():. PubMed ID: 35923311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 Spike Furin Cleavage Site and S2' Basic Residues Modulate the Entry Process in a Host Cell-Dependent Manner.
    Lavie M; Dubuisson J; Belouzard S
    J Virol; 2022 Jul; 96(13):e0047422. PubMed ID: 35678602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spike protein cleavage-activation mediated by the SARS-CoV-2 P681R mutation: a case-study from its first appearance in variant of interest (VOI) A.23.1 identified in Uganda.
    Lubinski B; Frazier LE; Phan MVT; Bugembe DL; Cunningham JL; Tang T; Daniel S; Cotten M; Jaimes JA; Whittaker GR
    bioRxiv; 2022 Mar; ():. PubMed ID: 34230931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico analysis of mutations near S1/S2 cleavage site in SARS-CoV-2 spike protein reveals increased propensity of glycosylation in Omicron strain.
    Beaudoin CA; Pandurangan AP; Kim SY; Hamaia SW; Huang CL; Blundell TL; Vedithi SC; Jackson AP
    J Med Virol; 2022 Sep; 94(9):4181-4192. PubMed ID: 35575289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spread of Gamma (P.1) Sub-Lineages Carrying Spike Mutations Close to the Furin Cleavage Site and Deletions in the N-Terminal Domain Drives Ongoing Transmission of SARS-CoV-2 in Amazonas, Brazil.
    Naveca FG; Nascimento V; Souza V; Corado AL; Nascimento F; Silva G; Mejía MC; Brandão MJ; Costa Á; Duarte D; Pessoa K; Jesus M; Gonçalves L; Fernandes C; Mattos T; Abdalla L; Santos JH; Martins A; Chui FM; Val FF; de Melo GC; Xavier MS; Sampaio VS; Mourão MP; Lacerda MV; Batista ÉLR; Magalhães ALÁ; Dábilla N; Pereira LCG; Vinhal F; Miyajima F; Dias FBS; Dos Santos ER; Coêlho D; Ferraz M; Lins R; Wallau GL; Delatorre E; Gräf T; Siqueira MM; Resende PC; Bello G;
    Microbiol Spectr; 2022 Feb; 10(1):e0236621. PubMed ID: 35196783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of SARS-CoV-2 Spike Mutations on Its Activation by TMPRSS2 and the Alternative TMPRSS13 Protease.
    Stevaert A; Van Berwaer R; Mestdagh C; Vandeput J; Vanstreels E; Raeymaekers V; Laporte M; Naesens L
    mBio; 2022 Aug; 13(4):e0137622. PubMed ID: 35913162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide bioinformatics analysis of human protease capacity for proteolytic cleavage of the SARS-CoV-2 spike glycoprotein.
    Matveev EV; Ponomarev GV; Kazanov MD
    Microbiol Spectr; 2024 Feb; 12(2):e0353023. PubMed ID: 38189333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
    Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
    J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve
    Shiliaev N; Lukash T; Palchevska O; Crossman DK; Green TJ; Crowley MR; Frolova EI; Frolov I
    J Virol; 2021 Oct; 95(21):e0135721. PubMed ID: 34406867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteolytic activation of SARS-CoV-2 spike protein.
    Takeda M
    Microbiol Immunol; 2022 Jan; 66(1):15-23. PubMed ID: 34561887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of polymorphisms at the S1/S2 site of SARS-CoV-2 spike protein.
    Arora P; Sidarovich A; Graichen L; Hörnich B; Hahn A; Hoffmann M; Pöhlmann S
    PLoS One; 2022; 17(3):e0265453. PubMed ID: 35333910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant.
    Liu Y; Liu J; Johnson BA; Xia H; Ku Z; Schindewolf C; Widen SG; An Z; Weaver SC; Menachery VD; Xie X; Shi PY
    bioRxiv; 2021 Sep; ():. PubMed ID: 34462752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteolytic cleavage of the SARS-CoV-2 spike protein and the role of the novel S1/S2 site.
    Jaimes JA; Millet JK; Whittaker GR
    SSRN; 2020 May; ():3581359. PubMed ID: 32714113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.